With Steve Hawkins, President & CEO of Horizons ETFs — Steve began his career in financial services in high school as a mail runner for a Bay Street brokerage firm. He attended the University of Toronto to study math and philosophy and his jobs during college included working on the trading floor. …

With Ahmad Doroudian, PhD, CEO at BetterLife Pharma — BetterLife Pharma CEO Ahmad Doroudian (PhD) sits down with TCF co-founding partner Henri Sant-Cassia for our latest edition of Conscious Conversations as they discuss unique value proposition, psychedelic investment, and how the future of psychedelic medicine is looking to shape up. …

Clubhouse Speaker Series — Jon was the first study participant for NYU’s clinical trial studying the affects of psilocybin on alcoholism. Prior to enrolling, Jon tried every treatment available, but sadly to no avail. Remarkably, since his first session, Jon has completely lost any urge to return to his drinking habits of old and…

TCFs Latest Offering — Since the inception of The Conscious Fund we’ve always understood that sometimes it’s best to lead by example. With a global footprint and connections to some of the brightest minds around the world we thought it best to take the bull by its horns and tackle one of the biggest…

With Peter Goldstein, CEO of Exchange Listing LLC — Throughout this series we’ll be focusing the conversation on all things psychedelic medicine & investments — Talking with leaders, purveyors and other members of the investment community to help add a little colour and insight. On our first episode of Conscious Conversations, co-founder and managing partner of The Conscious Fund…

Clubhouse Speaker Series — The Conscious Fund (TCF) Presents is a conversation series on Clubhouse which aims to educate and expand the dialogue around psychedelic medicine, venture capital, and the big ideas that look to shape our future with a focus around mental health & addiction. …

As the industry surrounding psychedelic medicine slowly makes its way into the mainstream, comparisons between compounds and industries have become more prevalent. Are any of these comparisons warranted? Today, we aim to dissect the facts surrounding psychedelic medicine. Go-to-Market Strategy: Conventional Regulatory Pathways & Breakthrough Therapy Acceleration While comparisons between the psychedelic renaissance and the boom of the cannabis…

Editor-In-Chief at DoubleBlind Magazine We sat down with Shelby Hartman, co-founder and editor-in-chief of DoubleBlind Magazine, a publication devoted to reporting on all things psychedelics. How and why did you get involved in the psychedelics? I got into psychedelics when I was 18 and I did mushrooms in college. And…

Founder & CEO at Mindleap Health We sat down with Nikolai Vassev, software developer and co-founder and CEO at Mindleap Health, a psychedelic integration app aimed to connect psychedelic medicine patients with mental healthcare professionals. How and why did you get involved in the psychedelics? My background is in software…